Abstract:It has been well known that WT1 gene is overexpressed in leukemia cells regardless subtypes comparing to normal hematopoietic cells. The precise effect of WT1, whether an oncogenic or tumor suppressive effect, in leukemogenesis remains controversial. Isoforms of WT1 protein products caused by alternative splicing may exert different biological function. To investigate the role of WT1 product composed of four major isoforms in certain ratios in hematopoietic cells, we have established a leukemia cell line NB4 which stably expressed exogenous WT1 gene isoforms, then studied their effects on cell biologic behaviors including proliferation, apoptosis and differentiation and its possible molecular mechanisms. The eukaryotic expression recombinant vectors (pCB6+/WT1) containing 4 clones of full-length human WT1 isoforms (WTA: −17aa/-KTS, WTB:+17aa/-KTS, WTC: −17aa/+KTS, WTD: +17aa/+KTS) cDNA were transduced into the leukemia cell line NB4 by electroporation.The positive stable cell clones (NB4/WT1) were obtained. The integration and expresion of WT1 gene isoforms in NB4 cells were confirmed by PCR. RT-PCR and western blotting. We then mainly concentrated on the effect of WT1 isoform WTA (−17aa/-KTS) since this transgene will markedly change the WT1 isoform ratio in NB4 cells from +17aa/+KTS dominant to −17aa/-KTS dominant. The proliferation ability was measured by trypan blue exclusion assay, MTT assay, colony forming assay and cell cycles analysis. Morphology, NBT reduction and CD11b expression were examined to access the cell differentiation. AnnexinV binding tested by FCM and agarose gel electrophoresis were performed to access the susceptibility to action of apoptosis inducing agents. Expressions of PML/RARα, RbAP46, P21, P53, Bcl-2, Bcl-XL and C-myc genes in NB4/WTA cells were determined by semi-quantitative RT-PCR DNA microarray was used to explore the alteration of gene expression profiles in NB4/WTA cells. The proliferation rate of NB4/WTA significantly decreased as measured by growth curves and colony forming ability, while the NB4/WTA cells arrested in S stage increased. NB4/WTA cells treated with ATRA 0.5μM for 2 days were induce to partially differentiate compared to a much higher morphological differentiation rate and CD11b expression level in the negative control cells in same condition. After exposure to As2O3 at 0.8μM for 48 hours, the NB4/WTA cells,but not the control cells, exhibited features of apoptosis RT-PCR have showed increasing level of PML/RARα, RbAP46, P21 and C-myc gene expression, a decreased level of Bcl-2 and a relative constant expression of P53,Bcl-XL, VEGF, CyclinD1 and CyclinD2 in NB4/WTA cells. The gene expression profiles were found changed in transfected NB4 cells. 89 of 4096(2.17%) genes were found to have a differential expression pattern, most of which (nearly 88.7%) were down-regulated. Our results indicated that overexpression of exogenous WT1 isoform (−17aa/-KTS) gene inhibited the proliferation of leukemia cells by delaying the progression of S into G2/M stage in cell cycle and inducing cell apoptosis by down-regulating the Bcl-2 gene expression. WTA gene could also partially inhibit the differentiation of NB4 cells. The introduction and expression of exogenous WT1 isoform gene can change the gene expression profiles in NB4 cells, leading to inhibition of cell growth, retardation of differentiation and more sensitive to apoptosis inducing agents.

WT1 Downregulation During K562 Cell Differentiation and Apoptosis Induced by Bufalin.

The Effect of WT1 Expression on the Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia

Bufalin Inhibits Htert Expression and Colorectal Cancer Cell Growth by Targeting CPSF4

Microarray and Biochemical Analysis of Bufalin-Induced Apoptosis of HL-60 Cells

Effect of Bufotalin on the Apoptosis of BGC-823 Cells

[Effects of Berbamine on K562 Cells and Its Mechanisms in Vitro and in Vivo].

Triptolide Down-regulates Bcr-abl Expression and Induces Apoptosis in Chronic Myelogenous Leukemia Cells

Study on Proteomics of HeLa Cell Apoptosis in Bufalin-Induced Human Cervical Carcinoma

Study on the Biological Functions of WT1 Gene Isoforms in Leukemia Cells.

Effect of extracellular signal-regulated kinase on the apoptosis induced by bufalin in K562 cells

Bufalin induces apoptosis of pancreatic cancer cells via the JNK signaling pathway

Apoptosis of Human Pancreatic Cancer Cell Induced by Bufalin and Its Effects on Survivin Expression in Nude Mice

Bufalin Induces Glioma Cell Death by Apoptosis or Necroptosis

Impact of MAPK signal pathway on inhibition of proliferation and promotion of apoptosis induced by bufalin in Jurkat cells

Role of the Wilms' Tumor 1 Gene in the Aberrant Biological Behavior of Leukemic Cells and the Related Mechanisms.

Bufalin Inhibits Tgf-Beta-Induced Epithelial-To-Mesenchymal Transition And Migration In Human Lung Cancer A549 Cells By Downregulating Tgf-Beta Receptors

Bufalin Induces Reactive Oxygen Species Dependent Bax Translocation and Apoptosis in ASTC-a-1 Cells

Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling

Bufalin induced apoptosis in SCC-4 human tongue cancer cells by decreasing Bcl-2 and increasing Bax expression via the mitochondria-dependent pathway

ERK inhibitor synergistic with bufalin induces K562 cells’ apoptosis

Bufalin induces apoptosis in the U‑2OS human osteosarcoma cell line via triggering the mitochondrial pathway.